Clinical Trials: 80% save their hair with Penguin Cold Caps

80% of patients saved their hair in a recent clinical trial using Penguin Cold Caps manual system, compared to 50% and 66% in prospective trials with machine-based scalp cooling devices, such as Paxman and Dignicap.

“90% of patients said
it was worth it”

The findings of a recent two-year pilot trial performed at Providence Portland Medical Center. with patients diagnosed with early-stage breast cancer, have now been published. The trial monitored patients’ experience and reported the efficacy of using Penguin Cold Caps while undergoing chemotherapy treatment.

The results

80% of patients saved more than 50% of their hair – which was the primary efficacy endpoint. However, most patients anecdotally saved more than 50%, with only one requiring the use of a headcover to conceal any hair loss. 20% of patients discontinued prematurely, and overall hair loss was not recorded.

Was it worth it?

90% of patients said it was worth it when asked. 100% saying they would recommend it to others. 80% saying they would undertake scalp cooling again.

Only 4.17% were upset by the amount of hair loss

87.5% said participation was an overall positive experience. The same number (87.5%) speculated that their quality of life would have decreased if they had lost their hair. They also cited a potential negative impact on their careers, privacy, self-esteem, and self-image if they had not kept their hair.

“Hair preservation impacted an
improvement in self-confidence”

It’s accepted that cold capping can be time-consuming and repetitive process. Patients universally agreed that training is of the utmost importance. The majority consider, efficacy dependent on the training received by the hands-on support of a caretaker (friend or family member) or the professional services of a qualified capper.